{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:27:27Z","timestamp":1790692047631,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T00:00:00Z","timestamp":1577923200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cannabis Res"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Trends toward legalizing cannabis may increase experimentation with the drug among less experienced users with limited knowledge of possible adverse reactions. This study explores the prevalence, frequency, and levels of distress produced by various acute adverse reactions to cannabis, as well as predictors of these reactions.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The Adverse Reactions Scale (ARS) was created and administered to a large sample of undergraduate college students (<jats:italic>n<\/jats:italic>\u2009=\u2009999) who were predominantly white (&gt;\u200970%), female (&gt;\u200970%), recreational (&gt;\u200990%) cannabis users. The ARS was administered in an anonymous online survey measuring demographics, cannabis use patterns, cannabis use motives, personality, and negative affect.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The most prevalent adverse reactions to cannabis were coughing fits, anxiety, and paranoia, which &gt;\u200950% of the sample reported experiencing. The most frequently occurring reactions were coughing fits, chest\/lung discomfort, and body humming, which occurred on approximately 30\u201340% of cannabis use sessions. Panic attacks, fainting, and vomiting were rated as the most distressing, with mean ratings falling between \u201cmoderately\u201d and \u201cquite\u201d distressing. Multiple regression analyses revealed that lower frequency of cannabis use predicted increased frequency of adverse reactions. Symptoms of cannabis use disorder, conformity motives, and anxiety sensitivity were significant predictors of both the prevalence of, and distress caused by, adverse reactions.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Relative to past research, this study provides a more comprehensive account of possible adverse reactions to cannabis, and individual difference variables that predict these reactions. This study has implications for inexperienced cannabis users, as well as medical professionals and budtenders who provide information about cannabis use.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s42238-019-0013-x","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T14:02:59Z","timestamp":1577973779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Overbaked: assessing and predicting acute adverse reactions to Cannabis"],"prefix":"10.1186","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5198-5722","authenticated-orcid":false,"given":"Emily M.","family":"LaFrance","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Stueber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C.","family":"Glodosky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dakota","family":"Mauzay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Cuttler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,2]]},"reference":[{"issue":"1","key":"13_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugalcdep.2010.02.017","volume":"110","author":"SJ Adamson","year":"2010","unstructured":"Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton L, Kelly BJ, Sellman JD. An improved brief measure of cannabis misuse: the Cannabis use disorders identification test-revised (CUDIT-R). Drug Alcohol Depend. 2010;110(1):137\u201343. https:\/\/doi.org\/10.1016\/j.drugalcdep.2010.02.017.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"13_CR2","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1017\/S0033291706009688","volume":"37","author":"M Arendt","year":"2007","unstructured":"Arendt M, Rosenberg R, Fjordback L, Brandholdt J, Foldager L, Sher L, Munk-J\u00f8rgensen P. Testing the self-medication hypothesis of depression and aggression in cannabis-dependent subjects. Psychol Med. 2007;37(7):935\u201345. https:\/\/doi.org\/10.1017\/S0033291706009688.","journal-title":"Psychol Med"},{"issue":"6","key":"13_CR3","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1017\/S0033291712001924","volume":"43","author":"Z. Atakan","year":"2012","unstructured":"Atakan Z, Bhattacharyya S, Allen P, Mart\u00edn-Santos R, Crippa JA, Borgwardt SJ, McGuire P. Cannabis affects people differently Inter-subject variation in the psychotogenic effects of \u03949-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers. Psychol Med. 2013;43(06):1255\u201367. https:\/\/doi.org\/10.1017\/S0033291712001924.","journal-title":"Psychological Medicine"},{"key":"13_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.addbeh.2014.09.003","volume":"40","author":"A Benschop","year":"2015","unstructured":"Benschop A, Liebregts N, van der Pol P, Schaap R, Buisman R, van Laar M, et al. Reliability and validity of the marijuana motives measure among young adult frequent cannabis users and associations with cannabis dependence. Addict Behav. 2015;40:91\u20135. https:\/\/doi.org\/10.1016\/j.addbeh.2014.09.003.","journal-title":"Addict Behav"},{"issue":"4","key":"13_CR5","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.addbeh.2004.08.027","volume":"30","author":"H Chabrol","year":"2005","unstructured":"Chabrol H, Ducong\u00e9 E, Casas C, Roura C, Carey KB. Relations between cannabis use and dependence, motives for cannabis use and anxious, depressive and borderline symptomatology. Addict Behav. 2005;30(4):829\u201340. https:\/\/doi.org\/10.1016\/j.addbeh.2004.08.027.","journal-title":"Addict Behav"},{"issue":"2","key":"13_CR6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40429-017-0142-2","volume":"4","author":"Marco Colizzi","year":"2017","unstructured":"Colizzi M, Bhattacharyya S. Does cannabis composition matter? Differential effects of delta-9-tetrahydrocannabinol and cannabidiol on human cognition. Current. Addiction Reports. 2017;4(2): 62\u201374. https:\/\/doi.org\/10.1007\/s40429-017-0142-2","journal-title":"Current Addiction Reports"},{"issue":"5","key":"13_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178194","volume":"12","author":"C Cuttler","year":"2017","unstructured":"Cuttler C, Spradlin A. Measuring cannabis consumption: psychometric properties of the daily sessions, frequency, age of onset, and quantity of Cannabis use inventory (DFAQ-CU). PLoS One. 2017;12(5):e0178194.","journal-title":"PLoS One"},{"issue":"10","key":"13_CR8","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1038\/sj.npp.1301643","volume":"33","author":"DC D\u2019Souza","year":"2008","unstructured":"D\u2019Souza DC, Ranganathan M, Braley G, Gueorguieva R, Zimolo Z, Cooper T, et al. Blunted psychotomimetic and amnestic effects of delta-9-tetrahydrocannabinol in frequent users of cannabis. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2008;33(10):2505\u201316. https:\/\/doi.org\/10.1038\/sj.npp.1301643.","journal-title":"Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology"},{"key":"13_CR9","volume-title":"SPSS for windows step by step: a simple guide for reference, 17.0 update (10a ed.)","author":"D George","year":"2010","unstructured":"George D, Mallery M. SPSS for windows step by step: a simple guide for reference, 17.0 update (10a ed.). Boston: Pearson; 2010."},{"issue":"3","key":"13_CR10","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1207\/s15327752jpa6603_3","volume":"66","author":"SO Lilienfeld","year":"1996","unstructured":"Lilienfeld SO, Andrews BP. Development and preliminary validation of a self-report measure of psychopathic personality traits in noncriminal populations. J Pers Assess. 1996;66(3):488\u2013524. https:\/\/doi.org\/10.1207\/s15327752jpa6603_3.","journal-title":"J Pers Assess"},{"issue":"3","key":"13_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","volume":"33","author":"PF Lovibond","year":"1995","unstructured":"Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the Beck depression and anxiety inventories. Behaviour Research & Therapy. 1995;33(3):335\u201343. https:\/\/doi.org\/10.1016\/0005-7967(94)00075-U.","journal-title":"Behaviour Research & Therapy"},{"key":"13_CR12","unstructured":"McCrae, R., & Costa, P. (2010). Professional manual for the NEO inventories: NEO-PI-3, NEO-PI-R, and NEO-FFI-3. Psychological Assessment Resources."},{"issue":"3","key":"13_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1037\/adb0000083","volume":"29","author":"E Moitra","year":"2015","unstructured":"Moitra E, Christopher PP, Anderson BJ, Stein MD. Coping-motivated marijuana use correlates with DSM-5 cannabis use disorder and psychological distress among emerging adults. Psychol Addict Behav. 2015;29(3):627\u201332. https:\/\/doi.org\/10.1037\/adb0000083.","journal-title":"Psychol Addict Behav"},{"key":"13_CR14","unstructured":"Mullaney, J. (2018). Horrible side effects of marijuana that people never talk about. Retrieved September 4, 2019, from showbiz cheat sheet website: https:\/\/www.cheatsheet.com\/health-fitness\/horrible-side-effects-marijuana-people-never-talk.html\/"},{"issue":"12","key":"13_CR15","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/jclp.21908","volume":"68","author":"A Osman","year":"2012","unstructured":"Osman A, Wong JL, Bagge CL, Freedenthal S, Gutierrez PM, Lozano G. The depression anxiety stress scales\u201421 (DASS-21): further examination of dimensions, scale reliability, and correlates. J Clin Psychol. 2012;68(12):1322\u201338. https:\/\/doi.org\/10.1002\/jclp.21908.","journal-title":"J Clin Psychol"},{"issue":"2","key":"13_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0887-6185(87)90002-8","volume":"1","author":"RA Peterson","year":"1987","unstructured":"Peterson RA, Heilbronner RL. The anxiety sensitivity index: construct validity and factor analytic structure. Journal of Anxiety Disorders. 1987;1(2):117\u201321. https:\/\/doi.org\/10.1016\/0887-6185(87)90002-8.","journal-title":"Journal of Anxiety Disorders"},{"key":"13_CR17","unstructured":"Rahn, B. (2016). What Are the Side Effects of High-THC Cannabis? Retrieved September 4, 2019, from Leafly website: https:\/\/www.leafly.com\/news\/cannabis-101\/what-are-the-side-effects-of-high-thc-cannabis"},{"issue":"1","key":"13_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26843","volume":"6","author":"JG Ramaekers","year":"2016","unstructured":"Ramaekers JG, van Wel JH, Spronk DB, Toennes SW, Kuypers KPC, Theunissen EL, Verkes RJ. Cannabis and tolerance: acute drug impairment as a function of cannabis use history. Sci Rep. 2016;6(1):1\u20138. https:\/\/doi.org\/10.1038\/srep26843.","journal-title":"Sci Rep"},{"issue":"1","key":"13_CR19","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/can.2016.0007","volume":"1","author":"M Sexton","year":"2016","unstructured":"Sexton M, Cuttler C, Finnell JS, Mischley LK. A cross-sectional survey of medical Cannabis users: patterns of use and perceived efficacy. Cannabis and Cannabinoid Research. 2016;1(1):131\u20138. https:\/\/doi.org\/10.1089\/can.2016.0007.","journal-title":"Cannabis and Cannabinoid Research"},{"issue":"3","key":"13_CR20","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/acm.2018.0319","volume":"25","author":"M Sexton","year":"2019","unstructured":"Sexton M, Cuttler C, Mischley LK. A survey of cannabis acute effects and withdrawal symptoms: differential responses across user types and age. J Altern Complement Med. 2019;25(3):326\u201335. https:\/\/doi.org\/10.1089\/acm.2018.0319.","journal-title":"J Altern Complement Med"},{"key":"13_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.26828\/cannabis.2019.01.001","volume":"2","author":"A Spradlin","year":"2019","unstructured":"Spradlin A, Cuttler C. Problems associated with using cannabis to cope. Cannabis. 2019;2:29\u201338. https:\/\/doi.org\/10.26828\/cannabis.2019.01.001.","journal-title":"Cannabis"},{"key":"13_CR22","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA) (2016). Marijuana (Cannabis). Retrieved from: https:\/\/www.samhsa.gov\/atod\/marijuana."},{"key":"13_CR23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.psychres.2017.07.070","volume":"257","author":"NP Vadhan","year":"2017","unstructured":"Vadhan NP, Corcoran CM, Bedi G, Keilp JG, Haney M. Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: a preliminary study. Psychiatry Res. 2017;257:372\u20134. https:\/\/doi.org\/10.1016\/j.psychres.2017.07.070.","journal-title":"Psychiatry Res"},{"issue":"23","key":"13_CR24","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219\u201327. https:\/\/doi.org\/10.1056\/NEJMra1402309.","journal-title":"N Engl J Med"},{"key":"13_CR25","unstructured":"WebMD (2018). How Marijuana Affects Your Mind and Body. (n.d.). Retrieved September 4, 2019, from WebMD website: https:\/\/www.webmd.com\/mental-health\/addiction\/marijuana-use-and-its-effects"}],"container-title":["Journal of Cannabis Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-019-0013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s42238-019-0013-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s42238-019-0013-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:33:15Z","timestamp":1609461195000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcannabisresearch.biomedcentral.com\/articles\/10.1186\/s42238-019-0013-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1186\/s42238-019-0013-x","relation":{},"ISSN":["2522-5782"],"issn-type":[{"value":"2522-5782","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,2]]},"assertion":[{"value":"14 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from all participants, and the Office of Research Assurances deemed this project to be minimal risk research and exempt from the need for IRB review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects gave consent for the results of this study to be published.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3"}}